Recently, Hou, et.al conducted RNA sequencing of HepG2 cancer cells treated with Bevacizumab and found that Bevacizumab triggers cancer cells ferroptosis through the VEGF/PI3K/HAT1/SLC7A11 axis (Hou et al. 2024). Here, SLC7A11 is linked to cancer.